These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27979375)

  • 1. Incidence, predictors and outcomes of hematoma after ICD implantation: An analysis of a nationwide database of 85,276 patients.
    Sridhar AR; Yarlagadda V; Kanmanthareddy A; Parasa S; Maybrook R; Dawn B; Reddy YM; Lakkireddy D
    Indian Pacing Electrophysiol J; 2016; 16(5):159-164. PubMed ID: 27979375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of haematoma after pacemaker and CRT device implantation on hospitalization costs, length of stay, and mortality: a population-based study.
    Sridhar AR; Yarlagadda V; Yeruva MR; Kanmanthareddy A; Vallakati A; Dawn B; Lakkireddy D
    Europace; 2015 Oct; 17(10):1548-54. PubMed ID: 25855676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
    Borne RT; Masoudi FA; Curtis JP; Zipse MM; Sandhu A; Hsu JC; Peterson PN
    JAMA Netw Open; 2021 Jan; 4(1):e2035470. PubMed ID: 33496796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and outcome of implantable cardioverter-defibrillator patients with and without cardiac resynchronization therapy: Comparison of 4384 patients from the German Device Registry to randomized controlled trials.
    Köbe J; Willy K; Senges J; Hochadel M; Kleemann T; Spitzer SG; Andresen D; Jehle J; Steinbeck G; Szendey I; Butter C; Brachmann J; Hoffmann E; Eckardt L
    J Cardiovasc Electrophysiol; 2022 Mar; 33(3):483-492. PubMed ID: 35028995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillators with end stage renal disease: Nationwide inpatient sample database results.
    Ayoub K; Fry E; Marji M; Masri A; Hesselson A; Ellison K
    Pacing Clin Electrophysiol; 2022 Jan; 45(1):124-131. PubMed ID: 34806769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of hematoma complications after device implant in the clopidogrel era.
    Kutinsky IB; Jarandilla R; Jewett M; Haines DE
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):312-8. PubMed ID: 20558847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes.
    Jędrzejczyk-Patej E; Mazurek M; Kotalczyk A; Kowalska W; Konieczny-Kozielska A; Kozielski J; Podolecki T; Szulik M; Sokal A; Kowalski O; Kalarus Z; Średniawa B; Lenarczyk R
    Europace; 2021 Jan; 23(1):113-122. PubMed ID: 33257952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of diabetes on clinical outcome of patients with heart failure undergoing ICD and CRT procedures: results from the German Device Registry.
    Kaya E; Senges J; Hochadel M; Eckardt L; Andresen D; Ince H; Spitzer SG; Kleemann T; Maier SSK; Jung W; Stellbrink C; Rassaf T; Wakili R
    ESC Heart Fail; 2020 Jun; 7(3):984-995. PubMed ID: 32068978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
    Marzec LN; Peterson PN; Bao H; Curtis JP; Masoudi FA; Varosy PD; Bradley SM
    JAMA Cardiol; 2017 May; 2(5):561-565. PubMed ID: 28122073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative management of oral anticoagulation in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillator.
    Afzal MR; Mehta D; Evenson C; Pinkhas D; Badin A; Patel D; Essandoh MK; Godara H; Tyler J; Houmsse M; Liu Z; Kalbfleisch SJ; Hummel JD; Augostini R; Weiss R; Daoud EG; Okabe T
    Heart Rhythm; 2018 Apr; 15(4):520-523. PubMed ID: 29146276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
    Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
    Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the Use and Complications of Cardiac Resynchronization Therapy Device Implantation in Chronic Kidney Disease Patients.
    Kichloo A; Solanki D; Berger R; Jamal S; Albosta M; Aljadah M; Khan MZ; Kanjwal K
    J Innov Card Rhythm Manag; 2023 Feb; 14(2):5339-5347. PubMed ID: 36874561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
    J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center.
    Grabowski M; Gawałko M; Michalak M; Cacko A; Kowara M; Kołodzińska A; Januszkiewicz Ł; Balsam P; Vitali Serdoz L; Winter J; Opolski G
    Cardiol J; 2019; 26(4):360-367. PubMed ID: 29611175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: A report from the National Cardiovascular Data Registry.
    Kipp R; Hsu JC; Freeman J; Curtis J; Bao H; Hoffmayer KS
    Heart Rhythm; 2018 Jun; 15(6):847-854. PubMed ID: 28987459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Cost-Effectiveness of Same-Day Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Implantation.
    Atherton G; McAloon CJ; Chohan B; Heining D; Anderson B; Barker J; Randeva H; Osman F
    Am J Cardiol; 2016 May; 117(9):1488-93. PubMed ID: 26993428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic Prophylaxis and Treatment in Early Cardiac Implantable Electronic Devices Infection.
    Alshoubaki O; Al Darabaa Z; Odat O; Qubbaj A; Alhyari R; Alshare S; Ghanma I
    Med Arch; 2021 Feb; 75(1):56-60. PubMed ID: 34012201
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.